Investor backs new medtech firm
A tech investor from Leeds, David Pearce, is launching a blood pressure monitoring solution, with the help of digital and e-commerce partners based within the Northern Powerhouse.
Leeds based Nephos Solutions and Tarilian Laser Technologies (TLT), a Hertfordshire-based global developer of medical devices, have coordinated the creation of a new company to launch ViCardio, which will launch the first aesthetic, high performance, luxury, TLT consumer wearable blood pressure device.
Firms supporting the launch include Leeds-based Calls9 and Communicate Europe; Statement in Wakefield; and Nuuk based in Manchester.
The firms said that unlike traditional blood pressure cuffs, the ViCardio product delivered a continuous and highly accurate blood pressure reading – similar to the output that is generated from an internal arterial line.
ViCardio will be launched to the consumer market through the Kickstarter crowdfunding platform in April, with delivery to the medical sector expected later in 2018 following TLT’s clinical trials at Bart’s Hospital in London.
Sandeep Shah, CEO of TLT & ViCardio, said: “Delivering a successful Medtech product now requires not only excellent design and manufacturing support, but also extensive skills and expertise in mobile applications, data analytics and e-commerce sales & marketing. TLT is delighted to be working with the wealth of talent available within the Northern Powerhouse and the energy that is being injected into the launch. This complements the extensive partnerships that we have nurtured across the globe”.
David Pearce, of ViCardio said: “We’re delighted to have formed a joint venture with one of the leading global developers of innovative medical technology. The fact that we are launching ViCardio™ from the North shows the range of digital and e-commerce talent we have in the Northern Powerhouse”.
